Associated European Reference Networks

European Reference Networks (ERNs) assemble THE European clinical expertise centres for rare diseases. Four ERNs form the clinical core of Solve-RD due to their unsolved RD cohorts, diagnostic research expertise and infrastructure. Each ERN established their own Data Interpretation Task Force.

In addition, two ERNs have recently joined the project as associated ERNs. They also contribute their unsolved RD cohorts and diagnostic research expertise via a Data Interpretation Task Force.

ERN-RND

ERN-RND focuses on rare movement and cognitive disorders such as ataxias, hereditary spastic paraplegias (HSPs), frontotemporal dementias (FTDs), and paroxysmal disorders. The following organisations are involved in and contributing to Solve-RD:

  • Beneficiaries: University Hospital Tübingen, Radboud UMC Nijmegen, INSERM Brain & Spine Institute, UCL Institute of Neurology
  • Associated partners: University of Ljubljana, Ljubljana, Slovenia (Borut Peterlin); University Hospital Schleswig-Holstein, Lübeck, Germany (Katja Lohmann); Vall d'Hebron Barcelona Campus Hospital, Barcelona Spain (Alfons Macaya); Semmelweis University, Budapest, Hungary (Peter Balisza, Judit Molnar); University of Cambridge, Cambridge, UK (Rita Horvath); Ghent University Hospital, Ghent, Belgium (Bruce Poppe, Dimitri Hemelsoet); Koç University, Istanbul, Turkey (Ayşe Nazlı Başak); University of Crete, Rethymno, Greece (Ioannis Zaganas)

ERN-EURO NMD

ERN-EURO NMD focuses on neuromuscular disorders (NMDs) such as congenital and limb girdle muscular dystrophies, hereditary neuropathies, congenital myasthenic syndromes, muscle chanellopathies, and mitochondrial NMDs. The following organisations are involved in and contributing to Solve-RD:

ERN-ITHACA

ERN-ITHACA focuses on rare congenital malformation syndromes and intellectual disability. The following organisations are involved in and contributing to Solve-RD:

ERN-GENTURIS

ERN-GENTURIS focuses on patients with one of the rare genetic tumour risk syndromes such as colorectal cancer, paragangliomas, and gastric cancer. The following organisations are involved in and contributing to Solve-RD:

  • Beneficiaries: Radboud UMC Nijmegen, University Hospital Bonn, IPATIMUP
  • Associated partners: Klinikum der Universität München, München, Germany (Elke Holinski-Feder); Catalan Institute of Oncology, Barcelona, Spain (Gabriel Capella); TU Dresden, Dresden, Germany (Evelin Schröck); University of Cambridge, Cambridge, UK (Marc Tischkowitz), MH Hannover, Germany (Bernd Auber)

ERN-EpiCare (associated ERN)

ERN-EpiCare focuses on Rare and Complex Epilepsies. The following organisations are involved in and contributing to Solve-RD:

ERN-RITA (associated ERN)

ERN-RITA focuses on rare immunodeficiency, autoinflammatory and autoimmune diseases. The following organisations are involved in and contributing to Solve-RD: